Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
IGM Biosciences, Inc. stock logo
IGMS
IGM Biosciences
$1.27
$1.27
$0.92
$22.50
$76.57M0.6480,746 shsN/A
JanOne Inc. stock logo
JAN
JanOne
$2.57
$0.22
$5.26
$20.03M2.16229,417 shs139,500 shs
Maxpro Capital Acquisition Corp. stock logo
JMAC
Maxpro Capital Acquisition
$5.80
+0.3%
$6.13
$7.50
$19.22
$77.88M0.0174,040 shs43,353 shs
Milestone Pharmaceuticals Inc. stock logo
MIST
Milestone Pharmaceuticals
$1.70
+1.2%
$1.71
$0.63
$2.75
$89.82M0.521.01 million shs866,536 shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
IGM Biosciences, Inc. stock logo
IGMS
IGM Biosciences
-0.78%0.00%0.00%+7.63%-85.44%
JanOne Inc. stock logo
JAN
JanOne
0.00%0.00%0.00%0.00%0.00%
Maxpro Capital Acquisition Corp. stock logo
JMAC
Maxpro Capital Acquisition
0.00%+4.13%+1.05%+18.61%+4,028.11%
Milestone Pharmaceuticals Inc. stock logo
MIST
Milestone Pharmaceuticals
+1.19%+13.33%+1.80%+39.34%+19.72%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
IGM Biosciences, Inc. stock logo
IGMS
IGM Biosciences
4.5962 of 5 stars
3.03.00.04.63.83.31.3
JanOne Inc. stock logo
JAN
JanOne
N/AN/AN/AN/AN/AN/AN/AN/A
Maxpro Capital Acquisition Corp. stock logo
JMAC
Maxpro Capital Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Milestone Pharmaceuticals Inc. stock logo
MIST
Milestone Pharmaceuticals
1.6247 of 5 stars
3.21.00.00.01.72.50.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
IGM Biosciences, Inc. stock logo
IGMS
IGM Biosciences
1.90
Reduce$5.50333.07% Upside
JanOne Inc. stock logo
JAN
JanOne
0.00
N/AN/AN/A
Maxpro Capital Acquisition Corp. stock logo
JMAC
Maxpro Capital Acquisition
0.00
N/AN/AN/A
Milestone Pharmaceuticals Inc. stock logo
MIST
Milestone Pharmaceuticals
2.40
Hold$7.00311.76% Upside

Current Analyst Ratings Breakdown

Latest JAN, MIST, JMAC, and IGMS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/5/2025
Milestone Pharmaceuticals Inc. stock logo
MIST
Milestone Pharmaceuticals
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeBuy$5.00
(Data available from 8/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
IGM Biosciences, Inc. stock logo
IGMS
IGM Biosciences
$2.68M28.57N/AN/A$1.67 per share0.76
JanOne Inc. stock logo
JAN
JanOne
$39.61M0.00N/AN/A($0.67) per share0.00
Maxpro Capital Acquisition Corp. stock logo
JMAC
Maxpro Capital Acquisition
N/AN/AN/AN/AN/AN/A
Milestone Pharmaceuticals Inc. stock logo
MIST
Milestone Pharmaceuticals
$1M90.88N/AN/A($0.33) per share-5.15
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
IGM Biosciences, Inc. stock logo
IGMS
IGM Biosciences
-$195.79M-$0.90N/AN/AN/A-36.81%-93.35%-24.15%N/A
JanOne Inc. stock logo
JAN
JanOne
-$7.81MN/A0.00N/AN/AN/A-359.71%-70.26%N/A
Maxpro Capital Acquisition Corp. stock logo
JMAC
Maxpro Capital Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
Milestone Pharmaceuticals Inc. stock logo
MIST
Milestone Pharmaceuticals
-$41.52M-$0.84N/AN/AN/AN/A-1,672.29%-83.09%N/A

Latest JAN, MIST, JMAC, and IGMS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2025Q2 2025
Milestone Pharmaceuticals Inc. stock logo
MIST
Milestone Pharmaceuticals
-$0.18-$0.20-$0.02-$0.20N/AN/A
7/31/2025Q2 2025
IGM Biosciences, Inc. stock logo
IGMS
IGM Biosciences
-$0.30$1.58+$1.88$1.58$3.20 million$143.62 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
IGM Biosciences, Inc. stock logo
IGMS
IGM Biosciences
N/AN/AN/AN/AN/A
JanOne Inc. stock logo
JAN
JanOne
N/AN/AN/AN/AN/A
Maxpro Capital Acquisition Corp. stock logo
JMAC
Maxpro Capital Acquisition
N/AN/AN/AN/AN/A
Milestone Pharmaceuticals Inc. stock logo
MIST
Milestone Pharmaceuticals
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
IGM Biosciences, Inc. stock logo
IGMS
IGM Biosciences
N/A
17.66
17.66
JanOne Inc. stock logo
JAN
JanOne
N/A
0.15
0.15
Maxpro Capital Acquisition Corp. stock logo
JMAC
Maxpro Capital Acquisition
N/AN/AN/A
Milestone Pharmaceuticals Inc. stock logo
MIST
Milestone Pharmaceuticals
4.06
4.97
4.67

Institutional Ownership

CompanyInstitutional Ownership
IGM Biosciences, Inc. stock logo
IGMS
IGM Biosciences
42.79%
JanOne Inc. stock logo
JAN
JanOne
6.27%
Maxpro Capital Acquisition Corp. stock logo
JMAC
Maxpro Capital Acquisition
73.18%
Milestone Pharmaceuticals Inc. stock logo
MIST
Milestone Pharmaceuticals
86.18%

Insider Ownership

CompanyInsider Ownership
IGM Biosciences, Inc. stock logo
IGMS
IGM Biosciences
57.00%
JanOne Inc. stock logo
JAN
JanOne
3.00%
Maxpro Capital Acquisition Corp. stock logo
JMAC
Maxpro Capital Acquisition
19.27%
Milestone Pharmaceuticals Inc. stock logo
MIST
Milestone Pharmaceuticals
19.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
IGM Biosciences, Inc. stock logo
IGMS
IGM Biosciences
19060.29 million25.93 millionOptionable
JanOne Inc. stock logo
JAN
JanOne
1708.98 million8.71 millionNot Optionable
Maxpro Capital Acquisition Corp. stock logo
JMAC
Maxpro Capital Acquisition
2,02113.43 million10.84 millionNot Optionable
Milestone Pharmaceuticals Inc. stock logo
MIST
Milestone Pharmaceuticals
3053.46 million43.04 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
IGM Biosciences stock logo

IGM Biosciences NASDAQ:IGMS

$1.27 0.00 (0.00%)
As of 08/14/2025

IGM Biosciences, Inc., a clinical-stage biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer and autoimmune and inflammatory diseases. It develops Aplitabart, a Death Receptor 5 Agonist IgM antibody for the treatment of colorectal cancer; imvotamab, a CD20 x CD3 bispecific IgM antibody to treat myositis, as well as for the treatment of systemic lupus erythematosus and rheumatoid arthritis that is Phase Ib clinical trial; and IGM-2644, a bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins for the treatment of autoimmune diseases. IGM Biosciences, Inc. has a collaboration and license agreement with Genzyme Corporation to generate, develop, manufacture, and commercialize IgM antibodies. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California.

JanOne stock logo

JanOne NASDAQ:JAN

JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through Biotechnology and Recycling segments. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. It also provides turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.

Maxpro Capital Acquisition stock logo

Maxpro Capital Acquisition NASDAQ:JMAC

$5.80 +0.02 (+0.35%)
As of 08/13/2025

Maxpro Capital Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Taipei City, Taiwan.

Milestone Pharmaceuticals stock logo

Milestone Pharmaceuticals NASDAQ:MIST

$1.70 +0.02 (+1.19%)
Closing price 08/15/2025 04:00 PM Eastern
Extended Trading
$1.68 -0.01 (-0.88%)
As of 08/15/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans, as well as with the Montreal Heart Institute, the WCN network, and other research centers. The company was incorporated in 2003 and is headquartered in Montréal, Canada.